The PRP18 gene, which had been identified in a screen for pre-mRNA splicing mutants in Saccharomyces cerevisiae, has been cloned and sequenced. Yeast strains bearing only a disrupted copy of PRP18 are temperature sensitive for growth; even at a low temperature, they grow extremely slowly and do not splice pre-mRNA efficiently. This unusual temperature sensitivity can be reproduced in vitro; extracts immunodepleted of PRP18 are temperature sensitive for the second step of splicing. The PRP18 protein has been overexpressed in active form in Escherichia coli and has been purified to near homogeneity. Antibodies directed against PRP18 precipitate the U4/U5/U6 small nuclear ribonucleoprotein particle (snRNP) from yeast extracts.
The splicing of pre-mRNA takes place in two sequential cleavage-and-ligation reactions (reviewed in references 26, 27, and 59). In the first step, the pre-mRNA is cut at the 5' splice site, releasing the first exon; concomitantly, the 5' phosphoryl group at the end of the intron is ligated to the 2' hydroxyl of an internal adenosine, yielding a branched RNA termed a lariat. In the second step, cleavage at the 3' splice site is accompanied by ligation of the two exons, yielding the product mRNA and releasing the intron as a lariat. Each cleavage and ligation step is thought to be a concerted, transesterification reaction in which the number of phosphodiester bonds is conserved. The identical reactions occur during group II self-splicing, leading to the hypothesis that RNA is also the catalyst in pre-mRNA splicing (36) . The splicing of pre-mRNA occurs on a large ribonucleoprotein particle (RNP) called the spliceosome (13, 24) , which consists of five small nuclear RNAs (snRNAs), Ul, U2, U4, U5, and U6, and a large but undetermined number of proteins (17, 25, 39, 53) .
pre-mRNA splicing occurs in all eukaryotes, and its mechanism appears to be conserved from yeasts to metazoans. Although much has been learned about the functions of the snRNAs and the splicing proteins, a complete accounting of the role of any of the splicing factors cannot presently be given. Each snRNA is part of a small nuclear RNP (snRNP) (reviewed in reference 44). The Ul and U2 snRNPs are involved in recognition of splice sites; Ul base pairs to the 5' splice site, and U2 base pairs to the branchpoint sequence (see reference 57 and previously cited reviews). The U4 snRNA base pairs to the U6 snRNA, and together they form a single snRNP (12, 29) . The U5 snRNP binds to the U4/U6 snRNP, forming a stable complex (9, 17, 39) . It is in this complex that U4, U5, and U6 enter the spliceosome (41, 61) , but they do not remain associated throughout the splicing reaction. U4 is apparently needed only for assembly of the spliceosome, and it leaves the spliceosome before the first cleavage reaction (76) . U6 appears to be involved in both steps of splicing (20) , and a catalytic role for the U6 snRNA in the splicing reaction has been proposed (14, 20, 67) . The role of the U5 snRNP has been difficult to uncover. It is a large particle, apparently containing more proteins than the other snRNPs (4) . Recent genetic evidence suggests a role for the U5 snRNP in the recognition of both the 5' and 3' splice sites (48, 49) .
A variety of proteins are required for splicing. They include proteins involved in recognition and selection of the 5' and 3' splice sites and of the branchpoint sequence (see cited reviews). Several proteins, known from genetic studies in Saccharomyces cerevisiae, appear to be RNA-dependent ATPases whose roles in splicing may be to alter the conformations of the snRNAs or the pre-mRNA or to ensure the fidelity of splicing (reviewed in reference 60). These ATPases are needed during the assembly of the spliceosome, during both steps of splicing, and for the release of the mRNA. Many proteins associated with snRNPs are known (reviewed in reference 44). For the most part, their functions are unknown, although they are clearly involved in the nuclear transport of snRNPs, in maintaining the structures of individual snRNPs, and in the interactions between snRNPs. Two of the best-studied snRNP proteins are the yeast PRP4 and PRP8 proteins. PRP4, a component of the U4 snRNP, is involved in the binding of U4/U6 to U5 (7, 11, 52, 75) ; PRP8 is part of the U5 snRNP and appears to contact the premRNA during splicing (35, 43, 72) .
In S. cerevisiae, screening of temperature-sensitive mutants for splicing defects has been the principal method for identifying splicing factors (46, 56, 71) . Such screens have yielded about 20 genes, known as PRP (for pre-mRNA processing) genes, required for splicing. The PRP18 gene, found by Vijayraghavan et al. (71) , was of particular interest because of its involvement in the second step of splicing. Both in vivo and in vitro, the second step of splicing was found to be inhibited when PRP18 was defective (70, 71) . At the restrictive temperature, splicing in most of the temperature-sensitive prp mutants is blocked at the first step, often as a result of failure of the spliceosome to assemble. In contrast, the involvement of PRP18 in the second step of splicing suggested that PRP18 might directly affect the formation of covalent bonds in splicing and that study of it could yield insights into the mechanisms of catalysis in splicing. We report here the sequencing of the PRP18 gene, the analysis of a null allele of PRP18, and the production of active PRP18 protein. We (51) , and BLAST (2) .
Complementation. Four plasmids, pDH101 to 104, were made by cloning the 2.5-kb BamHI-EcoRI, the 1.9-kb HindIII-EcoRI, the 1.2-kb BamHI-SphI, or the 1.1-kb BamHIEcoRV fragment (Fig. 1B) a The purity of PRP18 was estimated from SDS-PAGE; we did not attempt to determine the specific activity of PRP18. fragment was excised from pDH105, filled in with Klenow fragment, and ligated into the cut pAR3039. pDH111 was placed in E. coli BL21(DE3) (65) . After induction with isopropylthiogalactopyranoside (IPTG), about 10% of the cell protein was PRP18. The identity of the protein was confirmed by N-terminal sequencing of gel-purified protein.
Solubility of overproduced PRP18 was determined by the method of Nagai and Th0gersen (47) . PRP18 was mostly insoluble when cells were grown at 37°C but was completely soluble when cells were grown at 30°C. PRP18 was monitored during purification by sodium dodecyl sulfate (SDS)-PAGE, which was also used to estimate the purity of the protein. PRP18 migrated anomalously in SDS-polyacrylamide gels with an apparent molecular weight of 34,000. Table  1 shows the results of one purification of PRP18. Cleared lysates of E. coli BL21(DE3)/pDH111 were made with lysozyme and Brij 58 as described elsewhere (66) . Phenylmethylsulfonyl fluoride, leupeptin, pepstatin A, benzamidine, and aprotinin were included throughout the purification. Nucleic acid was removed from the lysate by precipitation with 0.5% polyethyleneimine. PRP18 remained in the supernatant and was precipitated with 45% (NH4)2SO4. The pellet was redissolved in buffer A (50 of splicing more completely than aB, but aoB immunoprecipitated snRNPs better than oA. Both antibodies met the specificity criteria described in Results, and affinity-purified antibodies were more similar. PRP18 was detected in Western blots of extracts from wild-type yeast cells by using the High Sensitivity Enzygraphic Web or the ECL system, essentially according to the manufacturers' instructions. For making affinity-purified antibodies, PRP18 was coupled to tresyl-activated agarose, ammonium sulfate-fractionated sera were loaded onto the column, and purified antibodies were eluted sequentially at pH 2.5 and 11.5 (28) . Immunoprecipitation of snRNPs. Yeast extracts for immunoprecipitations were made from strain SS330, EJ101, or CBO18a as described by Lin et al. (42) . Immunoprecipitations were carried out essentially as described previously (7) except that preincubation of extracts under splicing conditions was omitted unless specifically indicated; in addition, KCl was substituted for NaCl throughout. Northern blotting for the snRNAs was carried out as described previously (17) except that the U6 probe was derived from plasmid pT7U6 (22) . Blots were quantitated with a Molecular Dynamics PhosphorImager. U5 snRNA was depleted by addition of a large excess of two oligonucleotides complementary to bases 1 to 24 and to bases 124 to 139 of the U5 snRNA followed by a 30-min incubation at 30°C under splicing conditions. About 75% of the U5 snRNA was cut at least once (40) . Labeling of immunoprecipitated RNAwith cytidine 3',5'-[5'-32P]bisphosphate (pCp) was performed as described previously (19) .
Splicing reactions. Antibody inhibition of splicing was carried out as described by Banroques and Abelson (7) . For the assay of splicing at different temperatures, PRP18-depleted extract was prepared as described elsewhere (33) . Splicing reactions (42) were run at different temperatures by bringing the extract and the splicing cocktail to the target temperature and then mixing them. Quantitation was done with a Molecular Dynamics Phosphorlmager.
Nucleotide sequence accession number. The sequence shown in Fig. 1A has been assigned GenBank accession number L03536. RESULTS Sequence, disruption, and transcription of the PRP18 gene. A 2.5-kb fragment containing the PRP18 gene had been cloned in S. cerevisiae by complementation of the prpl8 temperature-sensitive phenotype (70) . Analysis of the segregation of theprpl8 temperature-sensitive allele and a URA3 gene integrated at the locus of the cloned gene showed that the cloned gene was indeed PRP18 (70) . The sequence of the 2.5-kb fragment has been determined and is shown in Fig.  1A . As shown in the schematic diagram in Fig. 1B , the sequenced region contains two open reading frames and part of the previously known STF2 gene (77) . By complementation, we found that the first of the two open reading frames is PRP18; the region bounded by the BamHI site in the vector and the EcoRV site (Fig. 1B) is sufficient to complement the prp18 temperature-sensitive defect, while the region bounded by the HindIII site and the EcoRI site in the vector does not complement.
The PRP18 protein is encoded by bases 269 through 1021 of the sequence (Fig. 1A) , giving a nearly neutral (calculated pI of 6.6) protein of 251 amino acids (aa) (28,400 kDa). We found no homology between PRP18 and other proteins in the data base (2, 51), nor did we find any known motifs in PRP18 (5 Fig. 2B . The major __________________ = transcript of PRP18 is 2,050 bp (A in Fig. 2) hich has been cloned from
We have raised antibodies in rabbits to gel-purified PRP18.
early identical alignments The antibodies can be used to detect PRP18 in Western blots either of the homologous of extracts from wild-type yeast cells (Fig. 3) . PRP18 was gene showed that it is not identified by its mobility and its absence from extracts of yeast lacking the PRP18 gene (Fig. 3, lane 6) . From a essential, we constructed comparison of the signal from PRP18 in lanes 1 and 3 of Fig.  gene The antibodies inhibited splicing (Fig. 4) . The second step ly the PRP18 gene could of splicing was substantially, but not completely, inhibited; itive defect, showing that 2/3 lariat and exon 1 intermediates accumulated, and there tused by the disruption of was a corresponding reduction in the amount of mRNA )ut the possibility that the produced. With large amounts of antibody, there was some, uption are viable because likely nonspecific, inhibition of the first step (Fig. 4) . A vast ragment of PRP18 protein excess of antibody was necessary to achieve good inhibition;
'RP18 gene, the sequence similar amounts were required in analogous experiments
shows that only a 68-aa with other splicing proteins (7, 16, 52) . The inhibition could from a splicing extract of a strain in which the U5 gene had been turned off; 5, total protein from a zymolyase-SDS lysis of yeast strain SS330; 6, total protein from a zymolyase-SDS lysis of yeast strain DH120R-1, in which the PRP18 gene had been disrupted. For this blot, affinity-purified antibody was used; PRP18 could also be detected with aPRP18, but several additional proteins were also detected. Some of the bands seen were also detected with the preimmune serum or when the primary antibody was omitted. PRP18 in yeast extracts appeared to have a slightly lower electrophoretic mobility than does PRP18 from E. coli; this difference may result from the large difference in the amounts of protein loaded in lanes 1 and 3. wt, wild type. kinetics of splicing in these extracts shows that depletion of PRP18 inhibits only the second step of splicing (33) . Inhibition of the second step is incomplete in depleted extracts, consistent with the idea that PRP18 is not absolutely required for splicing.
Immunoprecipitation of snRNPs. To determine whether PRP18 is associated with any of the snRNPs involved in splicing, we carried out a series of immunoprecipitation experiments with aPRP18. Antibodies directed against the PRP4 protein were used as positive controls in our experiments; PRP4 is a yeast U4 snRNP protein (7, 11, 52, 75) . Yeast extracts were incubated with antibody bound to protein A-Sepharose; bound RNA was extracted and run on a denaturing gel, which was probed for the Ul, U2, U4, U5, and U6 snRNAs. Results of such an experiment are shown in Fig. 5 . aPRP18 precipitated the U4, U5 (both S and L forms), and U6 snRNAs from a yeast extract. About 8% of the U4, 5% of the U5, and 4% of the U6 snRNAs were precipitated; these recoveries were somewhat lower than those seen in aPRP4 immunoprecipitations. The specificity of this precipitation was shown by several results. First, none of the snRNAs was precipitated by preimmune serum (Fig. 5) , and the same snRNAs were precipitated by affinitypurified antibody (not shown). Second, the precipitation was stable at moderate salt concentrations. At 50 mM KCI, there was some nonspecific precipitation of Ul and U2 (Fig. 5) as well as other RNA (determined by pCp labeling [7, 75] ), but between 100 and 300 mM KCl, the precipitation of U4, U5, and U6 showed only a small salt sensitivity (Fig. 5) . Immunoprecipitation of U4, U5, and U6 was also resistant to heparin (not shown), which is effective in disrupting nonspecific RNA-protein interactions (7, 17) . Finally, we have labeled the immunoprecipitated RNAs with pCp (data not shown). U4, USS, and USL were detected; U6 cannot be labeled with pCp (45) . Several other RNAs were also detected at about the same level as the U RNAs, but these varied in precipitations from different extracts (also seen in the studies reported in references 43 and 52). The pattern of pCp labeling of RNAs precipitated by aPRP18 was identical to that of RNAs precipitated by aPRP4, which had been shown to precipitate U4, U5, and U6 snRNAs. All of the data show that U4, U5, and U6 snRNAs are precipitated specifically by caPRP18.
The U4, U5, and U6 snRNPs are thought to form a single particle (17, 39) ; hence, the precipitation of all three snRNAs by axPRP18 might result from interaction between PRP18 and only one snRNP. We used two types of experiments to characterize the interactions between PRP18 and the snRNPs further. First, we performed immunoprecipitations at different salt concentrations or in the presence of ATP; second, we immunoprecipitated snRNAs from extracts which had been depleted of specific snRNAs. The precipitation of U4, U5, and U6 was not significantly affected by increasing the salt concentration from 100 to 300 mM; however, above 300 mM there was a sharp decrease in the precipitation of all of the snRNAs (Fig. 5) concentration was increased from 300 to 400 mM (data not shown). This decrease paralleled the decline in precipitation of U5 snRNA by aPRP4 (Fig. 5) (7) . We also tried to find preferential precipitation of one of the snRNAs by preincubating extracts under splicing conditions with ATP, which is thought to affect the conformation of the U4/U5/U6 snRNP (10, 17, 39) , or by adding heparin to the extracts. Neither of these changes individually affected the immunoprecipitation, but inclusion of both ATP and heparin sharply reduced the amounts of all the snRNAs precipitated (also observed with aPRP4 (7] ). We did not see preferential precipitation of any of the snRNAs under any conditions.
We carried out immunoprecipitations with axPRP18 from yeast extracts which had been depleted of either U5 or U6 snRNA. A U6-depleted extract was made in vitro by using a deoxyoligonucleotide and RNase H (22) . From this extract, aPRP18 precipitated normal amounts of both U4 and U5 (Fig. 6A) but very little U6. Added T7-transcribed U6 RNA can be assembled into snRNP (22) and was precipitated by aPRP18 (Fig. 6A ). This experiment shows that PRP18 binding to U4 and U5 does not require U6 and suggests that PRP18 does not interact with the U6 snRNP. aPRP4 precipitates U4 and U5 following depletion of U6, suggesting that U4 and U5 remain associated after destruction of U6 in yeast extracts (6) ; similar results were found in HeLa extracts (10) .
A U5-depleted extract was made from a yeast strain in which expression of the U5 snRNA could be regulated (50) . Splicing extract was made from this strain several generations after the U5 gene had been turned off, leading to a 15-fold depletion of U5 (Fig. 6B) (40, 50, 61) . aPRP18 precipitated only trace amounts of snRNAs from the U5-depleted extract (Fig. 6B) . Several results show that the failure of xPRP18 to precipitate snRNPs from this extract is a direct consequence of the absence of U5 and not a result of any other problems with this extract. First, Krinke and Abelson (40) have shown that some splicing activity can be restored to US-depleted extracts by the addition of U5 snRNA, suggesting that the extract is otherwise competent for splicing (see also reference 61). A small amount of added, T7-transcribed US could be precipitated by aPRP18 or by aPRP4 (Fig. 6B) . Second, PRP18 is present at wild-type levels in this extract and was seen in Western blots (Fig. 3,  lane 4) . Third, aPRP4 precipitated both U4 and U6 snRNAs from the US-depleted extract, although the ratio of U4 to U6 was higher than in wild-type extracts. Finally, a procedure for partially depleting US snRNA by using two deoxyoligonucleotides has been developed by Krinke and Abelson (40) . Precipitation of U4, US, and U6 from this extract by aPRP18 is reduced, consistent with the previous result. In summary, our results show that PRP18 binding to the U4/US/U6 snRNP requires US but not U6 and hence that PRP18 is likely part of the US snRNP.
We were not able to carry out a depletion of the U4 snRNA. Only one oligonucleotide has been reported to facilitate RNase H cleavage of the yeast U4 snRNA (75) , but destruction of U4 with this oligonucleotide does not abolish splicing activity (21) . It seems unlikely a priori that PRP18 interacts primarily with U4, since U4 leaves the spliceosome before PRP18 acts (76) . The failure of ctPRP18 to precipitate U4 in the absence of US confirms this idea.
Splicing at different temperatures in a PRP18-depleted extract. Two findings, that PRP18 is essential only for viability at high temperatures and that extracts immunodepleted of PRP18 retain some splicing activity (33), suggested to us that a PRP18-depleted extract might have no splicing activity at high temperatures. Correlations between in vivo and in vitro requirements for PRP proteins have been seen for several other proteins (46) . We assayed splicing in a PRP18-depleted extract (33) at different temperatures. Results of assays of splicing at 16, 23, 28 , and 32°C using preimmune* antibody-depleted and aPRP18-depleted extracts are shown in Fig. 7A . At each temperature, three time points were analyzed; the times selected at each temperature were different to account for differences in the reaction rates. Under standard splicing conditions (23°C), depletion of PRP18 greatly reduces the amount of mRNA produced (33) . The amount of mRNA made in the PRP18-depleted extract declined substantially as the temperature was increased from 16 to 32°C; mRNA was nearly undetectable in the 32°C reactions. In the parallel reactions using preimmune antibody-depleted extract, there was also a decrease in the amount of mRNA produced, but this decrease was much smaller than that seen in the aPRP18-depleted extracts.
In the absence of a well-defined kinetic model for splicing, it is not possible to give a definitive interpretation of these results. However, the following argument supports the idea that the PRP18-depleted extract is temperature sensitive for the second step of splicing. (The analysis of splicing kinetics is discussed in more detail in reference 33.) Quantitative analysis of the gel shown in Fig. 7A demonstrated that the first step of splicing was unaffected by depletion of PRP18 at all temperatures. Both the amounts of pre-mRNA and the amounts of products, defined as RNA beyond the first step of splicing, showed this result. The rate of the second step (k2) can be estimated from the time course shown in Fig. 7A , as described in the figure legend; the two rate constants, k2(pre) and k2(aPRP18), are graphed as functions of the temperature in Fig. 7B . While k2(pre) increased monotoni- ..
. We wondered whether a PRP18-depleted extract could be irreversibly heat inactivated by heating at 32°C. The PRP18-depleted extract was heated to 32°C for 20 min and then immediately assayed for splicing activity at 23°C (Fig. 7A) . Both steps of the splicing reaction were slowed by approximately twofold, but no specific inactivation of the second step was seen, implying that the change in the extract which leads to inhibition of the second step of splicing at 32°C was reversible. Heat inactivation of extracts from a ppl8 temperature-sensitive strain had been reported previously (70) . Since the defect in the prpl8 gene in this strain is not presently known, our results cannot be directly compared with this heat inactivation result.
DISCUSSION
The PRP18 gene was discovered in a screen of a bank of temperature-sensitive yeast strains for splicing mutants (71) , and initial work on PRP18 showed that it was involved in the second step of splicing (70, 71) . In the present work, we have demonstrated that PRP18 is a component of the U4/U5/U6 snRNP, binding principally to the U5 snRNP. We also have showed that PRP18 is not absolutely required for splicing at low temperatures but is required at higher temperatures. In a separate report, we will demonstrate that PRP18 is involved only in the second step of splicing. In extracts depleted of PRP18, intermediates in the splicing pathway accumulate; these intermediates can be chased to products by the addition of PRP18 in the presence or absence of ATP (33) .
We (32, 38) , remain bound to the snRNPs at much higher salt concentrations. The binding of PRP18 to U4, U5, and U6 was unaffected by ATP. The effect of ATP on the stability and formation of the U4/U5/U6 snRNP complex is not clear. In yeast cells, fractionation of snRNPs on nondenaturing gels (17) or by glycerol gradients (11) showed partial or complete (in the presence of heparin) dissociation of U4/U6 from U5 upon addition of ATP. Studies with antibody to PRP8, a yeast U5 protein, found that U4/U6 was bound to U5 only in the presence of ATP (43) ; this result is in accord with initial studies of HeLa snRNPs using glycerol gradients (10) . Work on PRP4 suggested only a small effect of ATP on U4/U5/U6 stability; however, in the presence of heparin, ATP apparently caused U5 to dissociate from U4/U6, since U5 could no longer be precipitated by aPRP4 (7) . Work using purified U4/U5/U6 snRNP from HeLa cells found no effect of ATP on U4/ U5/U6 formation and stability (8 (43) . The characteristics of PRP8 are quite different from those of PRP18. Antibodies to PRP8 inhibit the first step of splicing (35) , and otPRP8 precipitates only U5 from extracts; however, in the presence of ATP, aPRP18 precipitated U4 and U6 in addition to U5. Recently, Frank et al. (23) have used genetic methods to identify proteins (or RNAs) which interact with U5. They found four genes, named SLUl, SLU2, SLU4, and SLU7, whose products are involved in splicing and interact genetically with U5. Consistent with our results, they also found genetic interactions between PRP18 and U5. Bach et al. (4) have identified six proteins specific to the U5 snRNP in HeLa extracts. One of these is immunologically related to the yeast PRP8 protein (3, 54) , but it is unknown whether a PRP18 analog may be lurking among them.
An alternative interpretation of our immunoprecipitation data is that PRP18 is only part of the U4/U5/U6 snRNP particle, not part of any isolated snRNP. Such proteins are known in HeLa cells (8) . Some of our data support this interpretation. First, we were not able to precipitate U5 individually under any of the conditions tested. Second, conditions which are known to cause disassociation of U5 from the U4/U6 snRNP, including salt concentrations above 350 mM (7, 8) or incubations in the presence of ATP and heparin, greatly reduced the amount of precipitation of all snRNPs; the salt concentration above which aoPRP18 no longer precipitates snRNPs is the same as that above which aPRP4 no longer precipitates U5 snRNA. One result which is apparently not consistent with this interpretation is that atPRP18 still precipitated U4 and U5 when U6 had been depleted, suggesting that intact U4/U5/U6 is not required for snRNP binding by PRP18. Behrens and Luhrmann (8) have recently found five proteins which are present only in the U4/U5/U6 snRNP. These five proteins appear to be sufficient to promote the assembly of the U4/U5/U6 snRNP from purified U4/U6 and U5 snRNPs. One of these proteins is apparently labile during heat shock, and its absence is responsible for the absence of splicing in heat-shocked cells (69) . From the fractionation of these proteins, it appears that they dissociate from the snRNPs at moderate salt concentrations (less than 500 mM). If PRP18 is indeed specific to the U4/U5/U6 particle, then it is plausible that an analog of it may be found among these five proteins.
Although U5 snRNP has long been presumed to be involved in splicing, its role in splicing has been difficult to establish. U5 snRNP was found to be associated with the spliceosome (25) , and native gel experiments suggested that U5 joined the spliceosome with U4/U6 before the first reaction in splicing (9, 17, 39, 53) . The requirement for U5 in splicing was shown first by genetic experiments in yeast cells (50) . Recent results support the notion that U5 is involved early in splicing. First, in extracts depleted of U5 snRNP, only early splicing complexes, lacking U4 and U6, form (41, 61) . Second, suppression of mutations in the 5' splice site by mutations in loop I of the U5 snRNA implies a role for U5 in 5' splice site recognition (48) .
A role for U5 in the second step of splicing was suggested by the 3' splice site binding experiments of Chabot et al. (15) , a finding which was disputed by Bindereif and Green (9) . Both in vivo and in vitro depletion of U5 appeared to lead to preferential slowing of the second step of splicing (50, 73) ; however, since the evidence now supports an essential role for U5 in the first step of splicing, it would appear that these depletions were incomplete, and the results are difficult to interpret unambiguously. Evidence favoring the involvement of U5 in the second step of splicing has come from the recent genetic studies of Newman and Norman (49) , who found that mutations in the highly conserved loop I of U5 suppress mutations in the AG dinucleotide at the 3' splice site. Their results imply that U5 snRNA is involved in the recognition of the 3' splice site. The inferred interaction between loop I of U5 and the 5' and 3' splice sites led to the suggestion that U5 is involved in juxtaposing the splice sites, in a manner analogous to that found in group II self-splicing RNAs. Our results provide clear biochemical evidence that the U5 snRNP is involved in the second step of splicing. The antibody inhibition experiments show that PRP18 is involved in the second step of splicing. In a separate report, we present a kinetic analysis of splicing in an extract immunodepleted of PRP18. We show that PRP18 is involved exclusively in the second reaction of splicing (33) . Together with the results presented here showing that PRP18 is part of the U5 snRNP, our experiments imply a role for the U5 snRNP in the second step of splicing. While the genetic data imply a role for U5 in recognition of the 3' splice site, our results suggest that PRP18 is involved in splicing at the time of the ligation of the exons (33 
